Indian biotechnology firm Biocon has declared its results for the quarter ended December 2010. It has reported consolidated net profiit at Rs 101 crore as against Rs 80.9 crore, a growth of 24.85% on year-on-year basis.
Consolidated net sales jumped 14.65% to Rs 728 crore from Rs 635 crore (YoY).
Consolidated earning before interest, depreciation, tax and amortisation (EBIDTA) margin was at 23.3% in third quarter.
Numbers were better-than-expectations. CNBC-TV18 expected profit after tax at Rs 93 crore and revenues at Rs 710 crore.
Source: http://www.moneycontrol.com/
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment